Zydus Group acquires Melgain from Issar Pharma

Q.  Which group has strengthened its derma portfolio with the acquisition of Melgain used for treating vitiligo?
- Published on 10 Aug 16

a. Zydus Group
b. Ranbaxy
c. Sun Pharma
d. None of the above

ANSWER: Zydus Group
 
Zydus Group has strengthened its derma portfolio with the acquisition of Melgain used for the treatment of vitiligo from Hyderabad based Issar Pharma for an undisclosed amount
  • Zydus is working towards making treatment more affordable for people suffering from this skin disorder
  • It is a leading player in the skin de-pigmentation segment and acquisition of Melgain marks its foray into this segment of repigmentation.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲